The Enterprise Value as of December 2025 (TTM) for Annexin Pharmaceuticals AB (publ) (ANNX.ST) is 125.48M

According to Annexin Pharmaceuticals AB (publ)’s latest financial reports and current stock price. The company's current Enterprise Value is 125.48M. This represents a change of -98.65% compared to the average of 9.33B of the last 4 quarters.

Annexin Pharmaceuticals AB (publ) (ANNX.ST) Historical Enterprise Value (quarterly & annually)

How has ANNX.ST Enterprise Value performed in the past?

The mean historical Enterprise Value of Annexin Pharmaceuticals AB (publ) over the last ten years is 6.14B. The current 125.48M Enterprise Value has changed 104.43% with respect to the historical average. Over the past ten years (40 quarters), ANNX.ST's Enterprise Value was at its highest in in the September 2024 quarter at 29.95B. The Enterprise Value was at its lowest in in the June 2016 quarter at 0.

Annexin Pharmaceuticals AB (publ) (ANNX.ST) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Annexin Pharmaceuticals AB (publ) Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Annexin Pharmaceuticals AB (publ) (ANNX.ST) Average Enterprise Value

How has ANNX.ST Enterprise Value performed in the past?

The current Enterprise Value of Annexin Pharmaceuticals AB (publ) (ANNX.ST) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Annexin Pharmaceuticals AB (publ) (ANNX.ST) Enterprise Value vs. Peers

How is ANNX.ST’s Enterprise Value compared to its peers?

Annexin Pharmaceuticals AB (publ)’s Enterprise Value is less than Isofol Medical AB (publ) (148.95M), less than Lipum AB (publ) (336.26M), less than Initiator Pharma A/S (143.95M), greater than IRLAB Therapeutics AB (publ) (116.55M), less than Alzinova AB (publ) (200.41M), less than Enorama Pharma AB (publ) (178.42M), less than Clinical Laserthermia Systems AB (publ) (179.76M), greater than Karolinska Development AB (publ) (46.80M), less than Bio-Works Technologies AB (publ) (164.97M), less than Integrum AB (publ) (220.16M),

Build a custom stock screener for Annexin Pharmaceuticals AB (publ) (ANNX.ST) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Annexin Pharmaceuticals AB (publ) using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Annexin Pharmaceuticals AB (publ) (ANNX.ST) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Annexin Pharmaceuticals AB (publ) or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.